CIMETIDINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Cimetidine Hydrochloride patents expire, and when can generic versions of Cimetidine Hydrochloride launch?
Cimetidine Hydrochloride is a drug marketed by Dava Pharms Inc, Hospira, Luitpold, Teva Parenteral, Vintage Pharms Llc, Ani Pharms, Chartwell Molecular, Cycle, G And W Labs Inc, Pai Holdings Pharm, Pharm Assoc, and Pharmobedient Cnsltg. and is included in twenty-one NDAs.
The generic ingredient in CIMETIDINE HYDROCHLORIDE is cimetidine hydrochloride. There are twenty-five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the cimetidine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cimetidine Hydrochloride
A generic version of CIMETIDINE HYDROCHLORIDE was approved as cimetidine hydrochloride by PHARM ASSOC on January 27th, 1997.
Summary for CIMETIDINE HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 12 |
NDAs: | 21 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 57 |
Clinical Trials: | 62 |
Patent Applications: | 794 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CIMETIDINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for CIMETIDINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Assiut University | Early Phase 1 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Phase 2 |
Beijing Biostar Pharmaceuticals Co., Ltd. | Phase 2 |
Pharmacology for CIMETIDINE HYDROCHLORIDE
Drug Class | Histamine-2 Receptor Antagonist |
Mechanism of Action | Histamine H2 Receptor Antagonists |
Anatomical Therapeutic Chemical (ATC) Classes for CIMETIDINE HYDROCHLORIDE
US Patents and Regulatory Information for CIMETIDINE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dava Pharms Inc | CIMETIDINE HYDROCHLORIDE | cimetidine hydrochloride | INJECTABLE;INJECTION | 074428-001 | Apr 25, 1996 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pharm Assoc | CIMETIDINE HYDROCHLORIDE | cimetidine hydrochloride | SOLUTION;ORAL | 075560-001 | Mar 15, 2000 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hospira | CIMETIDINE HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | cimetidine hydrochloride | INJECTABLE;INJECTION | 074468-004 | Dec 29, 1994 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |